Delivery Order SPE2DB22D3501-SPE2DB24FWU60

Award Date 8/28/24
Potential Completion Date 8/29/24
Potential Value $26K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The $5,235.60 contract is for the supply of 4565978324 BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract has an ultimate completion date of October 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $36,649.29, is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract has an ultimate completion date of August 5, 2024 and is a firm-fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,735.83 firm fixed-price contract is for the supply of BRIDION 200 MG/2 ML VIAL 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of April 13, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $59,716.19 firm fixed-price contract is for the supply of 4565781552 - BRIDION 200 MG/2 ML VIAL 2ML, a medication used in anesthesia. The contract has an ultimate completion date of September 13, 2024. AmerisourceBergen is delivering these products under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,648.81, is for the supply of BRIDION 500 MG/5 ML VIAL 5ML medical products. The contract has a period of performance through November 4, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $29,214.68, is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product. It is a firm-fixed-price delivery order contract with an ultimate completion date of August 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite...
This is a $1,215.72 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BRIDION 200 MG/2 ML VIAL 2ML, a medical product, with a period of performance through February 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) to supply BRIDION 200MG/2ML 10S medical products. The $14,503.41 firm-fixed-price contract has a period of performance through June 23, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a $8,361.25 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a completion date of January 9, 2024, is for the supply of BRIDION 200 MG/2 ML VIAL 2ML medical products. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, the prime contractor, for the provision of BRIDION 200 MG/2 ML VIAL 2ML pharmaceuticals. The contract, worth $14,439.54, has an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. This delivery order is part...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWU60
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $26,287.61 firm fixed price contract is for the supply of BRIDION 200 MG/2 ML VIAL 2ML pharmaceutical products. The order has an ultimate completion date of August 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999 through December 2025. This IDC allows the DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs and medical supplies, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/27/24, 9:20 AM